From June 2, 2022 to July 31, 2022, the company has repurchased 851,981 shares, representing 4.11% for $2.07 million. With this, the company has completed the repurchase of 851,981 shares, representing 4.11% for $2.07 million under the buyback announced on June 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | +1.65% | 0.00% | -6.48% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.48% | 16.8M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on June 2, 2022.